Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Sangamo Second Quarter 2023 Teleconference Call. At this time, all participants are in a listen-only mode.
Posts Tagged ‘NASDAQ:SGMO’
5 DNA Stocks Billionaires Are Loading Up On
In this article, we discuss 5 DNA stocks that billionaires love.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Sangamo First Quarter 2023 Teleconference Call. At this time, all participants are in a listen-only mode.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q4 2022 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and thank you, for standing by. Welcome to the Sangamo Fourth Quarter 2022 Earnings Conference Call.
10 Best Gene Editing Stocks To Buy
A report by The Wall Street Journal dated September 16 suggests that Intellia Therapeutics, Inc.
Were Hedge Funds Right About Selling Sangamo Therapeutics, Inc. (SGMO)?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Wasatch Global on Sangamo (SGMO): “We Remain Optimistic About its Future Prospects”
Wasatch Global Investors, an investment management firm, published its “Wasatch Ultra Growth Fund” first quarter 2021 investor letter – a copy of which can be downloaded...
Is Sangamo Therapeutics (SGMO) Stock a Buy For 2021?
Wasatch Ultra Growth Fund recently released its Q4 2020 Investor Letter, a copy of which you can download here.
Is Sangamo Therapeutics, Inc. (SGMO) A Good Stock To Buy?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Did Hedge Funds Make The Right Call On Sangamo Therapeutics, Inc. (SGMO) ?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Hedge Funds Are Getting Crazy About Sangamo Therapeutics, Inc. (SGMO)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
Hedge Funds Are Dumping Sangamo Therapeutics, Inc. (SGMO)
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
Is Sangamo Therapeutics, Inc. (SGMO) Going to Burn These Hedge Funds?
Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock...
Here’s What Hedge Funds Think About Sangamo Therapeutics, Inc. (SGMO)
There are several ways to beat the market, and investing in small cap stocks has historically been one of them.
Here’s What Hedge Funds Think About Sangamo Therapeutics, Inc. (SGMO)
Insider Monkey has processed numerous 13F filings of hedge funds and famous investors to create an extensive database of hedge fund holdings.
13G Filing: Adage Capital Management and Sangamo Therapeutics Inc (SGMO)
You can access the original SEC filing by clicking here.
36 Major Stories Telling What’s Happening in the World of Finance Today
"U.S. and European stocks fell on Thursday, along with the U.S. dollar, while U.S.
Is Sangamo Biosciences, Inc. (SGMO) a Good Stock to Invest in?
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Here’s Why Investors Are Watching Sangamo Biosciences, GNC Holdings, and Three Other Stocks Today
Markets are mixed on Wednesday as investors get ready to digest a flurry of earnings, and await Federal Reserve’s summary of commentary of the current economic condition, also...
Earnings Wrap: Transocean (RIG), XPO Logistics (XPO), Exelixis (EXEL), 2 More
All three index futures are pointing north in pre-market trading as the Bank of England just announced that it would cut interest rates for the first time in seven years, to ...
Can Sangamo Biosciences, Inc. (SGMO) Win the Battle Against its Market Cap Peers?
The 700+ hedge funds and money managers tracked by Insider Monkey have compiled and submitted their 13F filings for the third quarter, which unveiled their equity positions as...
One Tech Stock Made Investors Happy Today & One Healthcare Company You Should Follow Hedge Funds Into
One of the stocks that stands out on Thursday is Envivio Inc (NASDAQ:ENVI).
Wayne Holman, Ridgeback Capital Like Sangamo Biosciences
Wayne Holman, Ridgeback Capital: Wayne Holman's hedge fund Ridgeback Capital Management recently disclosed the purchasing of some 3.6 million shares of Sangamo Biosciences, ...
Biotech-Focused Hedge Fund is Bullish on ChemoCentryx Inc (CCXI)
Tracking the activity of hedge funds via their filings with the Securities and Exchange Commission is particularly crucial, since these filings reveal the latest moves made by...
Hedge Funds Are Selling Emergent Biosolutions Inc (EBS)
To many investors, hedge funds are viewed as delayed, outdated financial vehicles of a forgotten age.
ChemoCentryx Inc (CCXI): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
ChemoCentryx Inc (NASDAQ:CCXI) was in 6 hedge funds' portfolio at the end of March. CCXI has experienced an increase in enthusiasm from smart money recently.
Should You Buy Protalix BioTherapeutics Inc. (PLX)?
At the moment, there are many indicators shareholders can use to watch the equity markets. Two of the most innovative are hedge fund and insider trading activity.
Sangamo Biosciences, Inc. (SGMO): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
In the 21st century investor’s toolkit, there are a multitude of metrics market participants can use to track stocks.
Sangamo Biosciences, Inc. (SGMO), Tesla Motors Inc (TSLA) & The Never-Ending Comparison
In my portfolio, I hold a small position in a small biotech company by the name of Sangamo Biosciences, Inc. (NASDAQ:SGMO).
